A carregar...
Emerging Immunotherapies for Parkinson Disease
Symptomatic treatment options for Parkinson disease have steadily improved, and individualized therapeutic approaches are becoming established for every stage of the disease. However, disease-modifying therapy with a causal approach is still unavailable. The central causative role of alpha-synuclein...
Na minha lista:
| Publicado no: | Neurol Ther |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Healthcare
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6534677/ https://ncbi.nlm.nih.gov/pubmed/30539376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-018-0122-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|